Kamakshi Sishtla

6PUBLICATIONS
25CO-AUTHORS
Biologically active moleculesVision scienceNanomedicineHealth and ecological risk assessmentNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 31, 2026
Sulphur Analogues of Homoisoflavonoids as Potential Treatments for Neovascular Eye Diseases.

Jacob D Hiles, Ola Deri, Kamakshi Sishtla

|Feb 04, 2025
Ref-1 redox activity regulates retinal neovascularization by modulating transcriptional activation of HIF-1α.

Gabriella D Hartman, Anbukkarasi Muniyandi, Kamakshi Sishtla

|Nov 08, 2023
Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy.

Dhawal Chobisa, Anbukkarasi Muniyandi, Kamakshi Sishtla

|Jan 21, 2023
Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.

Mahmut Mijit, Sheng Liu, Kamakshi Sishtla

|Dec 23, 2022
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization.

Bomina Park, Sheik Pran Babu Sardar Pasha, Kamakshi L Sishtla

|Aug 05, 2018
Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.

Sheik Pran Babu Sardar Pasha, Kamakshi Sishtla, Rania S Sulaiman

Pageof 1

Frequent Collaborators

6 joint publications

Timothy W Corson

3 joint publications

Gabriella D Hartman

3 joint publications

Mark R Kelley

2 joint publications

Bomina Park